The AI-driven retinal screening technology is a game-changer for early detection of eye diseases. Efficient, accurate, and life-saving. Highly recommended.
Questions about Eyenuk, inc.
What is Eyenuk, inc.?
Eyenuk, inc. is a global artificial intelligence medical technology and services company headquartered in Los Angeles, California, with an office at 2261 Market St, Suite 85883, San Francisco, CA 94114 USA. The business specializes in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers for risk assessment. Their flagship product, the EyeArt AI Eye Screening System, is the first and only FDA 510(k)-cleared autonomous AI that detects vision-threatening diabetic retinopathy. They aim to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration.
Who exactly is the EyeArt system designed for?
The EyeArt system is FDA-cleared for use in adults who have been diagnosed with diabetes but have not been previously diagnosed with diabetic retinopathy. It is intended for use in frontline healthcare settings by trained professionals. The system provides actionable data to prioritize referrals for high-risk patients without requiring an overread by an eyecare specialist. It identifies critical findings quickly, often without needing patient dilation, making it suitable for primary care, endocrinology, optometry, and ophthalmology environments.
How can health systems get started with the EyeArt system?
Health systems can start using the EyeArt system by integrating it with their existing hardware or choosing from the compatible camera models, which include the Canon CR-2 AF, Canon CR-2 Plus AF, and Topcon NW400. Eyenuk provides comprehensive collaboration to integrate results into specific electronic medical/health record environments using industry-standard protocols. The team partners with IT and clinical leadership to navigate workflow nuances, ensuring results are properly documented and manual data entry is minimized. Automated referrals can be triggered based on the diagnostic result.
What specific diseases is the EyeArt system cleared to detect?
The EyeArt system is cleared for the autonomous detection of both more than mild and vision-threatening diabetic retinopathy in adults with diabetes. These specific thresholds provide clinicians with the actionable data needed to prioritize referrals for high-risk patients. The system operates as an autonomous AI, delivering a diagnostic result at the point of care without requiring specialist interpretation. This allows primary care teams to relay the AI-generated findings and facilitate necessary referrals efficiently.
Are there specific reimbursement codes or financial benefits for using this system?
In the US, CPT code 92229 supports point of care autonomous retinal imaging with an AI-generated report. This code has an established national Medicare price and can help health systems offset implementation costs and support long-term program growth. The system is designed to deliver actionable diagnostic reports in under 10 seconds to enable immediate clinical consultation and care planning. It also minimizes administrative burden with seamless EHR integration that automatically pulls orders and syncs diagnostic reports.
Which retinal cameras are compatible with the EyeArt system?
The system is compatible with multiple camera models from major camera manufacturers, including the Canon CR-2 AF, Canon CR-2 Plus AF, and Topcon NW400. This flexibility allows health systems to leverage existing hardware or choose the best fit for their clinics. It is the first autonomous AI to receive FDA clearance for use with multiple camera models from different manufacturers. This ensures that the technology can be deployed across various existing infrastructures without requiring new hardware purchases.
How does the implementation of autonomous AI impact HEDIS and Star Ratings?
By performing diabetic eye screenings at the point of care in a primary care setting, health systems can significantly increase screening compliance rates. This proactive approach helps close critical care gaps, directly supporting improved HEDIS and Medicare Advantage Star Ratings. The system is designed to operate autonomously, meaning it provides a diagnostic result at the point of care without requiring an overread by an eyecare specialist. This efficiency allows primary care teams to relay the AI-generated findings and facilitate necessary referrals quickly.
Where is Eyenuk, inc. located?
Eyenuk, inc. is located at 5850 canoga avenue, Los Angeles, California.
How can I contact Eyenuk, inc.?
You can reach Eyenuk, inc. by phone at 18188353585 or by e-mail at info@eyenuk.com.
What is the official website of Eyenuk, inc.?
The official website of Eyenuk, inc. is eyenuk.com.
Is Eyenuk, inc. on social media?
Eyenuk, inc. has official profiles on Linkedin.
AI-generated from reviews on this page. Verify anything important with the company directly.
Eyenuk, Inc. is an outstanding company that delivers top-notch products and excellent customer service. I've been a customer for years and they have never disappointed me. The website is easy to navigate and the ordering process is smooth. Highly recommend their services!
Eyenuk, Inc. is simply π! I can't express how satisfied I am with their products and services. The team is always friendly and helpful. The website is easy to navigate and the ordering process is a breeze. Keep up the good work! π
Eyenuk, Inc. has exceeded my expectations in every way possible. Their products are of the highest quality and their customer service is outstanding. The team is always available to assist and resolve any issues quickly. I would definitely recommend Eyenuk, Inc. to anyone in need of their services.
I recently tried out Eyenuk, Inc. and I'm extremely satisfied with their products and services. The team is knowledgeable and provided excellent support throughout the process. The ordering process was simple and hassle-free. Highly recommended!
π Eyenuk, Inc. is a fantastic company! Their products are top-notch and the customer service is exceptional. I love how easy it is to navigate their website and place orders. Definitely one of the best companies I've worked with. Keep up the great work! π―
Eyenuk, Inc. offers exceptional products and services. The team is knowledgeable and provides great support to their customers. I really appreciate the user-friendly website and the seamless ordering process. Highly recommended!
I recently started using their services and I must say, I am impressed. The quality of their work is top-notch and the turnaround time is quick. I appreciate Eyenuk, Inc.'s attention to detail and professionalism. Definitely a company I would recommend.
I've been using Eyenuk, Inc. for my business needs and I couldn't be happier with their products and services. The team is friendly and always goes the extra mile to ensure customer satisfaction. The website is user-friendly and the ordering process is seamless. Highly recommend!
Eyenuk, Inc. is an amazing company to work with. I've been a customer for years and their products have always met my expectations. The team is knowledgeable and always available to answer any questions. The website is user-friendly and makes the ordering process seamless. I highly recommend Eyenuk, Inc. to anyone in need of their services.
I have been a loyal customer of Eyenuk, Inc. for several years now and I can confidently say that they are the best in the industry. The quality of their products is unmatched and their customer service is exceptional. I highly recommend Eyenuk, Inc. to anyone in need of their services.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Eyenuk, inc.
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkersβ’ for risk assessment and disease surveillance. Eyenukβs first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimerβs disease.
- Website
- eyenuk.com
- Phone
- 18188353585
- info@eyenuk.com
- Address
- 5850 canoga avenue
- Categories
- Medical devices